Y. Ishii et al., Cold activation of serum complement in patients with chronic hepatitis C: Study on activating pathway and involvement of IgG, ACT MED OKA, 55(4), 2001, pp. 229-235
It has been documented that the serum complement activities measured by hem
olytic assay (CH50) are decreased after storage of sera at a low temperatur
e in some patients with chronic hepatitis C. However, the mechanism of this
phenomenon has not been identified yet. Here, we tried to elucidate factor
s involved in the cold activation of complement (CAC). To clarify what path
way is activated in CAC, we measured complement cleavage products after col
d storage of sera. C4d increased significantly after 12 h-storage at cold t
emperatures in 5 CAC (+) sera compared with 5 CAC (-) (P < 0.01) and 3 cont
rol sera (P < 0.05), while Bb did not increase in any of the groups. In ord
er to determine whether IgG or IgG complex is necessary for CAC, 8 CAC (+)
sera were incubated with Protein G Sepharose gel beads, and all of them ret
ained hemolytic activities to some extent after cold storage. Column chroma
tography through Superose 6HR of CAC-positive serum identified the fraction
s containing molecules that induced CAC in normal serum, which were deplete
d by treatment with protein G Sepharose. In conclusion, CAC in hepatitis C
seems to occur via a classical or lectin pathway, and the IgG complex produ
ced in hepatitis C virus infection may be an important factor in inducing C
AC, a common extrahepatic manifestation of hepatitis C.